WEDNESDAY, MARCH 29, 2017

New West Nile Virus vaccine begins human clinical trials

A new investigational vaccine for West Nile Virus infection prevention recently began its human clinical trial stage, which is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), a branch of the National Institutes of Health. Read More »

Panel updates WHO on Ebola outbreak in West Africa

The World Health Organization (WHO) released a statement Tuesday about the recent International Health Regulations Emergency Committee meeting on the Ebola outbreak that occurred in West Africa. The meeting was held to advise the WHO director-general about whether Ebola remains a public health emergency of international concern Read More »

Novation commits to customers as bird flu impacts US egg production

Novation said Tuesday it is showing its commitment to its customers by continuing to deliver its products despite how avian influenza, also known as highly pathogenic avian influenza (HPAI), has affected egg production in the U.S. Read More »

Pfizer launches Phase 2b trial of multi-antigen Staphylococcus aureus vaccine

Pfizer, Inc. said Tuesday it has enrolled its first patient in the company’s Phase 2b clinical trial for its investigational Staphylococcus aureus (S. aureus) multi-antigen vaccine (P-06290510) for adults having elective spinal fusion surgery. Read More »

C. difficile requires specific amounts of iron to grow--but not too much

A team of researchers recently discovered that Clostridium difficile, known as C. difficile, requires a specific amount of iron to grow, but too much iron will oxidize the bacteria. Read More »

Royal DSM honors scientists around the world

Bright Science campaign also aims to encourage discussion about the importance of science. Read More »

New anti-tuberculosis drug may be found in local pharmacies

Over-the-counter antacid found to be effective in combating deadly disease. Read More »

Researchers find new methods to eliminate malaria parasite

Scientists from the Toxicology Unit of the Medical Research Council (MRC) at the University of Leicester and the London School of Hygiene & Tropical Medicine recently discovered a new method to eliminate malaria parasites. Read More »

Mosquitoes bring West Nile virus to New Mexico

Mosquitoes spread West Nile Virus each year, and now New Mexico is one of the few states that has reported human cases of West Nile Virus during this year’s rainy season. Read More »

AXON's Alzheimer’s vaccine completes Phase 1 trial

AXON Neuroscience said July 2 that its innovative vaccine for Alzheimer’s disease (AD) recently finished its Phase 1 safety trial. AXON, a biotech firm, said it created the vaccine to give hope to the millions of people afflicted with Alzheimer’s, their caregivers, their loved ones and their physicians. Read More »

Minnesota officials investigate suspected primary amebic meningoencephalitis case

The Minnesota Department of Health (MDH) is conducting an investigation of a suspected case of primary amebic meningoencephalitis (PAM) in a child who is critically ill. Read More »

Chikungunya virus antibodies developed

Large panel of antibody treatments against mosquito-borne virus developed by Vanderbilt researchers Read More »

Shanchol oral cholera vaccine may aid global control effort

The first real-life trial of Shanchol, an oral cholera vaccine that is part of regular health services, recently showed that it effectively protects people against contracting cholera, which may help health officials in their global control efforts, researchers said Wednesday. Read More »

West Nile virus activity spreads across California

No human cases reported so far, according to state's department of public health. Read More »

FDA approves Flublok influenza vaccine for 2015-16

Protein Sciences Corp. recently announced that the U.S. Food and Drug Association (FDA) has approved the company’s Flublok influenza vaccine composition for the 2015-16 flu season. Read More »

CDC commits to eliminating Ebola

The Centers for Disease Control and Prevention (CDC), along with its partners, recently unveiled a multimedia report showing the experiences that the CDC’s Ebola responders have had since the Ebola epidemic first started in early 2014 in West Africa. Read More »

BiondVax’s universal flu vaccine continues forward motion

M-001, the BiondVax Pharmaceuticals Ltd. candidate for a universal influenza vaccine, is showing positive results from its phase two clinical trial, says President and CEO Dr. Ron Babecoff. Read More »

Scripps study shows drug therapy candidate decreases HIV reactivation rate

Scientists from The Scripps Research Institute’s (TSRI) Florida campus said Wednesday they designed a drug candidate that significantly decreases the HIV reactivation site. Read More »

Roll Back Malaria Partnership announces elimination strategies

The Roll Back Malaria Partnership recently announced its new strategies that are designed to help global efforts achieve the goal of malaria elimination by 2030. Read More »

Chicago expands vaccination locations to control meningitis outbreak

The Chicago Department of Public Health (CDPH) recently announced that it is expanding its vaccination locations to control an ongoing meningitis outbreak in the Chicago area. Read More »